Previous Close | 0.0250 |
Open | 0.0000 |
Bid | 0.0250 x N/A |
Ask | 0.0300 x N/A |
Day's Range | 0.0000 - 0.0000 |
52 Week Range | |
Volume | |
Avg. Volume | 972,138 |
Market Cap | 9.134M |
Beta (5Y Monthly) | 3.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF)("Empower" or the "Company") a life sciences healthcare company - serving patients through medical centers, a medical device company and the application of clinical studies that leverages it's high complexity medical diagnostics laboratory - today announced that it signed a deal with PulseIR, a wholly-owned subsidiary of Fobi AI Inc, to deliver personalized, automated, and data-driven mobile investor relations
EMPOWER CLINICS INC (CSE:EPW) (OTC PINK:EPWCF)("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - announced that Medi+Sure Canada Inc. ("MediSure") next generation diabetes testing solutions - MediSure Empower Test Strips - have been approved to be part of the formularies of four government jurisdictions, departments
EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF)("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - announces that it is offering units ("Units") of the Company at $0.03 per Unit (the "Issue Price").